🇺🇸 FDA
Patent

US 12350250

Aggrelytes for treating ocular conditions

granted A61KA61K31/198A61K31/223

Quick answer

US patent 12350250 (Aggrelytes for treating ocular conditions) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/198, A61K31/223, A61K31/265, A61P